These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6692744)

  • 1. Lactulose-induced hypernatremia.
    Nanji AA; Lauener RW
    Drug Intell Clin Pharm; 1984 Jan; 18(1):70-1. PubMed ID: 6692744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypernatremia and lactulose therapy.
    Nelson DC; McGrew WR; Hoyumpa AM
    JAMA; 1983 Mar; 249(10):1295-8. PubMed ID: 6827705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypernatremia after the administration of lactulose.
    Kaupke C; Sprague T; Gitnick GL
    Ann Intern Med; 1977 Jun; 86(6):745-6. PubMed ID: 869354
    [No Abstract]   [Full Text] [Related]  

  • 4. Pneumatosis coli following treatment with lactulose.
    Zimmerman AL; Gupta JK; Ingegno AP
    N Y State J Med; 1979 Nov; 79(12):1896-9. PubMed ID: 292844
    [No Abstract]   [Full Text] [Related]  

  • 5. Lactulose: how many ways can one drug be prescribed?
    Lukens B; Nierman DM; Schiano TD
    Am J Gastroenterol; 2011 Sep; 106(9):1726-7. PubMed ID: 21897418
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic encephalopathy.
    Fraser CL; Arieff AI
    N Engl J Med; 1985 Oct; 313(14):865-73. PubMed ID: 2993889
    [No Abstract]   [Full Text] [Related]  

  • 7. Lactulose and severe lactic acidosis.
    Mann NS; Russman HB; Mann SK; Tsai MF
    Ann Intern Med; 1985 Oct; 103(4):637. PubMed ID: 3839989
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose.
    Hammer HF; Santa Ana CA; Schiller LR; Fordtran JS
    J Clin Invest; 1989 Oct; 84(4):1056-62. PubMed ID: 2794043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactulose for hepatic encephalopathy.
    Med Lett Drugs Ther; 1976 Jan; 18(1):3-4. PubMed ID: 1105127
    [No Abstract]   [Full Text] [Related]  

  • 10. Lactulose: a crucial element in treating hepatic encephalopathy.
    Gever LN
    Nursing; 1982 Aug; 12(8):76-8. PubMed ID: 6920588
    [No Abstract]   [Full Text] [Related]  

  • 11. Quiz Page November 2016: Kidney and Neurologic Complications in the Treatment of a Patient With Hepatic Encephalopathy.
    Pena-Polanco JE; Rondon-Berrios H
    Am J Kidney Dis; 2016 Nov; 68(5):A15-A17. PubMed ID: 27772635
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy].
    Sala Felis T; Berenguer J; Barrios JM; Gómez J
    Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
    Morgan MY; Alonso M; Stanger LC
    J Hepatol; 1989 Mar; 8(2):208-17. PubMed ID: 2654285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study.
    Loguercio C; Del Vecchio Blanco C; Coltorti M
    J Int Med Res; 1987; 15(6):335-43. PubMed ID: 3125077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients].
    Grandi M; Sacchetti C; Pederzoli S; Celani MF
    Minerva Gastroenterol Dietol; 1991; 37(4):225-30. PubMed ID: 1805974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactulose-induced megacolon.
    Wright RA
    Gastrointest Endosc; 1988; 34(6):489-90. PubMed ID: 3234693
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
    Patil DH; Westaby D; Mahida YR; Palmer KR; Rees R; Clark ML; Dawson AM; Silk DB
    Gut; 1987 Mar; 28(3):255-9. PubMed ID: 3570029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifaximin for the treatment of hepatic encephalopathy.
    Mantry PS; Munsaf S
    Transplant Proc; 2010 Dec; 42(10):4543-7. PubMed ID: 21168733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.
    Heredia D; Terés J; Orteu N; Rodés J
    J Hepatol; 1988 Aug; 7(1):106-10. PubMed ID: 3053887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.